Navigation Links
Nektar Therapeutics to Present at the Deutsche Bank 34th Annual Health Care Conference in Boston
Date:5/12/2009

SAN CARLOS, Calif., May 12 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) is scheduled to present at the upcoming Deutsche Bank 34th Annual Health Care Conference in Boston at the Boston InterContinental Hotel on Monday, May 18, 2009 at 1:45 p.m. Eastern time.

The presentation will be accessible via a Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website: http://www.nektar.com. This Webcast will be available for replay until June 10, 2009.

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies. Nektar is also developing a robust pipeline of its own potentially high-value therapeutics that addresses unmet medical needs by leveraging and expanding its technology platforms to improve and enable molecules. For more information on Nektar Therapeutics, please visit http://www.nektar.com. 

    Nektar Contacts:

    Jennifer Ruddock
    Nektar Therapeutics
    650-631-4954
    jruddock@nektar.com

    Susan Noonan
    The SAN Group
    212-966-3650
    susan@sanoonan.com


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Nektar to Announce Third Quarter 2007 Financial Results on Wednesday, November 7, 2007, After the Close of U.S. Financial Markets
2. Nektar Therapeutics Announces Third Quarter 2007 Financial Results
3. Nektars Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York
4. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
5. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
6. Nektar to Announce 2007 Year-End Financial Results on Wednesday, February 27, 2008, After Close of U.S.-Based Financial Markets
7. Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results
8. FDA Approval of Cimzia(R) for Crohns Disease Represents Latest Milestone for Nektars PEGylation Technology Platform
9. Nektar Therapeutics Announces First Quarter 2008 Results
10. Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
11. Nektar Therapeutics Announces Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... of remaining recurrence-free, research shows , , TUESDAY, Feb. ... are genetic profiles that play a part in prognosis ... depending on the age and gender of the patient. ... 787 patients who were divided into subgroups based on ... findings are published in the Feb. 10 issue of ...
(Date:2/9/2010)... vitamin D begins in the womb, expert says, , , ... mothers who drink lots of milk and have a ... a much lower risk of developing multiple sclerosis later ... 35,794 U.S. nurses whose mothers provided information about their ... for 16 years, and 199 of them developed multiple ...
(Date:2/9/2010)... low folic acid, high blood pressure restrict fetal growth, ... The lifestyle habits you bring into pregnancy can have ... , A Dutch study found that women who smoked, ... in early pregnancy had babies that were smaller in ... risk of complications later. , "Our study demonstrates that ...
(Date:2/9/2010)... Watchdog Also Warns Against Insurer-favored ,Cost Solution,: Selling Policies ... Apartment" ,, WASHINGTON , Feb. 9 ... for lawmakers and regulators with its premium hikes of ... Watchdog. In the face of questions from the White ... commissioner, federal and state lawmakers should act to regulate ...
(Date:2/9/2010)... The following statement is ... M.D., President, American Medical Association: ,, (Logo: ... Medical Association is pleased to support First ... Let,s Move Campaign. As the nation,s largest ... address obesity and are committed to reenergizing ...
Breaking Medicine News(10 mins):Health News:Genes Play Role in Prognosis With Non-Small Cell Lung Cancers 2Health News:Drinking Milk While Pregnant May Lower Kids' MS Risk 2Health News:Mom's Lifestyle in Early Pregnancy Affects Baby's Size 2Health News:Mom's Lifestyle in Early Pregnancy Affects Baby's Size 3Health News:Blue Cross Claim That 39% Premium Hikes Due Only to 'Escalating Cost of Health Care' Trigger Calls for Regulation of Rates 2Health News:Blue Cross Claim That 39% Premium Hikes Due Only to 'Escalating Cost of Health Care' Trigger Calls for Regulation of Rates 3
... (UNC) at Chapel Hill have revealed that inhaling hypertonic saline ... fibrosis (CF). Hypertonic saline// is a water-based salt solution ... arrived at this conclusion after testing 24 patients aged 14 ... salt solution improved the health of the lungs and the ...
... of the both wine and beer drinkers. It was found ... when compared to those of beer drinkers. This was attributed ... ,Morten Gr?nb?k, M.D., Ph.D. and colleagues of the Danish ... The researchers started to survey the items bought by ...
... Christopher Smith, Member of African Subcommittee, House Committee on ... house to house AIDS testing and counseling as done ... been found very effective in early diagnosis of HIV ... against HIV positive person due to ignorance about the ...
... A single tablet which is taken once a day for treating ... Squibb Co and Gilead Sciences Inc. The regimen of three drugs ... receive a formal approval towards end 2006. //As many as 40 ... poor nations accounting for most of the numbers. The US is ...
... of New Jersey (Rutgers) revealed that curry spice turmeric ... in the treatment of prostate cancer.// ... cress, broccoli, Brussels sprouts, kale, kohlrabi and turnips. ... combination is very effective in the treatment of prostate ...
... in for wholesome and healthy food, beer drinkers are attracted ... among// wine drinkers when compared to beer drinkers. Now ... have found that beer drinkers buy unhealthy food such as ... according to BBC News. ,Studying 3.5 million ...
Other Medicine News:Health News:Wine Drinkers Good Health, Attributed To Their Lifestyle 2
(Date:2/9/2010)... TechTeam Global, Inc ., (Nasdaq: ... technology outsourcing and business process outsourcing services, announced ... director of global life sciences services. Roumans will ... ongoing capability enhancement in support of TechTeam,s life ... of experience in the life sciences industry, most ...
(Date:2/9/2010)... , February 9 Hoya Corporation ... December 31, 2009 .,Net sales were 106.8 billion ... 112.7,billion yen in the same period last ... 13.8% increase from 16.6 billion yen in ... orders and productivity. Compared to the second,quarter ended ...
(Date:2/9/2010)... , Feb. 9 Sanofi-aventis (EURONEXT: ... that it has successfully completed its tender offer for ... ( CHTT).   ,, The tender offer and withdrawal ... time, on February 8, 2010 .  The ... as of the expiration time, approximately 18,611,072 shares of ...
Breaking Medicine Technology:TechTeam Global Appoints Life Sciences Services Director 2TechTeam Global Appoints Life Sciences Services Director 3Hoya Announces Third Quarter Financial Results 2Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 2Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 3Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 4Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 5How do we fund plant breeding 3F 10551 1How do we fund plant breeding 3F 10551 2How do we fund plant breeding 3F 10551 3Cranberries Provide Eight Hour Health Protection 60228 1Cranberries Provide Eight Hour Health Protection 60228 2Cranberries Provide Eight Hour Health Protection 60228 3Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 1Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 2Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 3Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 4Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 5
ArcticTemp Upright Freezer -20C. Quick, even freezing. Heavy duty compressor. Deep door racks. Front gated bottom shelf. Interior light. Locks One year warranty on unit and 5 year warranty on compres...
... The F 265 is a highly accurate ... mV and temperature measurements. Temperature compensated pH results ... probe (ATC) or a 3-in-1 electrode. • This ... connect to a printer or a computer. Up ...
... swing doors, 12 shelves. Over-sized compressor. Triple ... interior lighting. Self-Contained System No plumbing required. ... Full One Year Warranty on Parts & Labor ... Also available as a chromatography unit ...
... 3 slide doors, 12 shelves.Over-sized compressor. ... Fluorescent interior lighting. Self-Contained System No plumbing ... Full One Year Warranty on Parts & ... Compressor. Also available as a chromatography ...
Medicine Products: